Macmillan launches Banking on Change campaign calling for banks to support cancer patients
Last week, Macmillan launched their Banking on Change campaign, calling for banks, [...]
What triggers kidney cancer cells to metastasise?
Researchers at the University of California in San Diego, USA, [...]
Adjuvant therapy for high risk kidney cancer
Dr Umberto Capitanio from the Department of Urology, San Raffaele [...]
The impact of immunotherapy on the treatment of kidney cancer
Professor Thomas Powles, Barts Cancer Institute, London discusses the impact [...]
Majority of people in the UK do not know that obesity can increase the risk of some cancers
A new study from Cancer Research UK and published in [...]
Risk factors for bone metastases from renal cell carcinoma
Data from 372 people with renal cell carcinoma (RCC) were [...]
Sunitinib approved by the FDA for adjuvant treatment of advanced kidney cancer
The US Food and Drug Administration (FDA) has approved sunitinib [...]
Joint working project between the Royal Marsden and Novartis to improve cancer services
A new joint working project between Novartis and the Royal [...]
Kidney cancer vaccine shows promise in early clinical trial
Results from a phase I clinical trial of a vaccine [...]
Nivolumab improves survival of kidney cancer patients at three years
Updated results from the phase 3 CheckMate-025 study, presented at [...]
